Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania

Abramson Cancer Center of the University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104-4283.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Abramson Cancer Center of the University of Pennsylvania has participated in 361 clinical trials with 47 currently active.

Therapeutic areas: Breast Cancer, Sarcoma, Uterine Cancer.

Sponsors: NSABP Foundation Inc, Alliance for Clinical Trials in Oncology, Abramson Cancer Center at Penn Medicine.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center of the University of Pennsylvania?

Abramson Cancer Center of the University of Pennsylvania has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center of the University of Pennsylvania conducted?

Abramson Cancer Center of the University of Pennsylvania has 361 clinical trials on record, with 47 currently active. Their work covers Breast Cancer, Sarcoma, Uterine Cancer.

Is Abramson Cancer Center of the University of Pennsylvania accredited by Crixeo Health?

Abramson Cancer Center of the University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center of the University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.